Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Shares Outstanding (Diluted Average) (2016 - 2023)

Ekso Bionics Holdings (EKSO) has disclosed Shares Outstanding (Diluted Average) for 11 consecutive years, with $13.3 million as the latest value for Q1 2023.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 4.46% to $13.3 million in Q1 2023 year-over-year; TTM through Mar 2023 was $13.3 million, a 4.46% increase, with the full-year FY2022 number at $13.0 million, up 5.65% from a year prior.
  • Shares Outstanding (Diluted Average) was $13.3 million for Q1 2023 at Ekso Bionics Holdings, up from $13.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $13.3 million in Q1 2023 to a low of $5.0 million in Q3 2019.
  • A 5-year average of $10.6 million and a median of $12.3 million in 2021 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): crashed 91.77% in 2019, then soared 111.16% in 2021.
  • Ekso Bionics Holdings' Shares Outstanding (Diluted Average) stood at $5.0 million in 2019, then surged by 43.37% to $7.2 million in 2020, then skyrocketed by 71.26% to $12.3 million in 2021, then grew by 5.65% to $13.0 million in 2022, then increased by 2.58% to $13.3 million in 2023.
  • Per Business Quant, the three most recent readings for EKSO's Shares Outstanding (Diluted Average) are $13.3 million (Q1 2023), $13.0 million (Q4 2022), and $12.9 million (Q3 2022).